CClinicalTrials.gg
Not yet recruitingNCT07127666ASKidsUpdated Jul 22, 2026

ASKids! Inpatient Agenda-Setting Study for Hospitalized Children With Medical Complexity

An interventional study of Structured Agenda-Setting Tool in Medical Complexity, sponsored by Dartmouth-Hitchcock Medical Center. Not yet recruiting at 1 site in United States. Open to participants aged 7 Years and older. Per ClinicalTrials.gov, last updated 2026-07-22.

Sponsored by Dartmouth-Hitchcock Medical Center · Not applicable, Interventional, and Health services research

Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Not applicable
Ages
7 Years and older
Sex
All
01

Study summary

The goal of this open pilot is to co-design and test a clinical agenda-setting intervention in the inpatient pediatric environment. We pilot a co-designed structured agenda-setting intervention (SAS) for multi-family meetings about children with medical complexity. Our open pilot will evaluate the feasibility and acceptability of using the SAS during routine multidisciplinary family meetings (MFM) at Dartmouth Hitchcock Medical Center. By doing an open pilot, researchers will learn if the agenda-setting instrument and implementation process are feasible and acceptable to patients, their care partner and their clinicians.

Read the detailed description

In this open pilot, the researchers will adapt and administer a novel structured agenda-setting tool (SAS) in the inpatient pediatric environment. The researchers will determine if their procedures for screening eligible participants, administering the intervention, and administering outcome and other questionnaires are appropriate. Learnings from the open pilot will feed forward into procedures in applications for larger trials of the intervention.

This study only has one arm, the intervention arm. The intervention, the co-adapted SAS, will be administered to all enrolled participants.

Future Directions: This open pilot will provide preliminary data for potential future larger trials.

02

Conditions studied

  • Medical Complexity

Keywords

  • clinical agenda-setting
  • pediatric inpatient care
03

In context

Lead sponsor

Dartmouth-Hitchcock Medical Center is the lead sponsor of 472 studies on the registry; 68 are open to participants now.

Of its 30 completed or terminated interventional studies of FDA-regulated products, 20 (67%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
7 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Pediatric Inpatients: Children aged 7-17 years
  • Can communicate in English
  • Able to provide verbal assent, with consent from their care partner
  • Dartmouth Hitchcock Medical Center pediatric patient who currently or has recently (within the last 3 months) been hospitalized with a length of stay of 4≥ days Care Partners: - Adults aged 18≥ years
  • Can communicate in English
  • Able to provide verbal consent
  • Care partners of Dartmouth Hitchcock Medical Center pediatric patients who are currently or have recently (within the last 3 months) been hospitalized with a length of stay of 4≥ days

Exclusion criteria

Exclusion Criteria:

  • For pediatric inpatients, children \< aged 7
  • For care partners, children aged \<18 years
  • Cannot communicate in English
  • For pediatric inpatients, unable to provide verbal assent
  • For care partners, unable to provide consent
  • Prisoners
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
20 participants (estimated)

Study arms

  • Experimental
    Treatment (Implements Structured Agenda-Setting Intervention)

    The study team will implement a structured clinical visit agenda-setting (SAS) intervention customized for the pediatric inpatient environment.

    Other: Structured Agenda-Setting Tool

Interventions

  • OtherStructured Agenda-Setting Tool

    We are testing a novel clinical visit agenda-setting intervention developed through participatory research methods for the pediatric inpatient environment. This structured agenda-setting (SAS) intervention will be co-designed to include structured discussion topic areas with the option for patients (when appropriate) and their care partners to consider and indicate their priority topic areas and take notes before, during, and after a clinical visit.

06

What researchers measure

Primary outcomes

  1. Primary Outcome: Feasibility

    Our primary outcome will be feasibility, assessed by the proportion of patients who receive the intervention.

    Time frame: Immediately after intervention delivery

Secondary outcomes

  1. Primary Process Outcome: Enrollment Rate

    Description: As measured by participant enrollment in REDCap.

    Time frame: Immediately after intervention delivery

Other outcomes

  1. Primary Preliminary Efficacy: Communication Assessment Tool (CAT)

    15-item patient-reported communication tool, with minor context-specific adaptations

    Time frame: Immediately after intervention delivery

  2. Secondary preliminary efficacy: Serious Illness Experience

    Serious illness experience measured by the consideRATE questions; a validated 8-item, plain language (2nd grade) patient-reported experience measure (PREM) with Likert-like response options for patients, and care partners

    Time frame: Immediately after intervention delivery

07

Study locations

1 site
  • Dartmouth Hitchcock
    Lebanon, New Hampshire 03756-1000, United States
08

References and documents

Publications

  • Sierpe A, Yen RW, Stevens G, Van Citters AD, Elwyn G, Saunders CH. Agenda-setting in the clinical encounter: A systematic review protocol. PLoS One. 2024 Oct 24;19(10):e0312613. doi: 10.1371/journal.pone.0312613. eCollection 2024. PubMed 39446854 ↗
  • Saunders CH, Durand MA, Kirkland KB, MacMartin MA, Barnato AE, Elwyn G. Psychometric assessment of the consideRATE questions, a new measure of serious illness experience, with an online simulation study. Patient Educ Couns. 2022 Jul;105(7):2581-2589. doi: 10.1016/j.pec.2022.01.002. Epub 2022 Jan 22. PubMed 35260261 ↗

Individual participant data

Plan to share: Yes — We will de-identified quantitative open pilot data available.

Supporting information: Study protocol

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 22, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07127666
Lead sponsor
Dartmouth-Hitchcock Medical Center
Collaborators
National Center for Advancing Translational Sciences (NCATS)
Responsible party
Catherine Hylas Saunders (Principal Investigator of the Healthcare Experience Lab (HEx Lab), Dartmouth-Hitchcock Medical Center) — Principal investigator
First posted
Aug 17, 2025
Start date
Aug 1, 2026 (estimated)
Primary completion
Nov 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
Jul 22, 2026

Study contacts

Catherine H. Saunders, PhD, MPH
Contact
Catherine.Hylas.Saunders@dartmouth.edu
603-653-3436
Anne E Dade, MPP
Contact
anne.e.dade@dartmouth.edu

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion